Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with PTGX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
PTGX
Protagonist Therapeutics, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
PTGX, dashed
LLY
ELI Lilly & Co
Change
1,411.70
▼
−0.41%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
PTGX
Protagonist Therapeutics, Inc
Change
141.91
▼
−2.03%
Regular session
Nov 2 '26
Mkt cap
$9.4B
Revenue
$213M
Q2 FY26
Revenue
$46M
FY25
vs
Compare
Regular session
Nov 2 '26
LLY
ELI Lilly & Co
vs
PTGX
Protagonist Therapeutics, Inc
1,411.70
▼
−0.41%
Price
141.91
▼
−2.03%
$1.3T
Mkt cap
$9.4B
Q3 FY26
$24.4B
Revenue
$213M
Q2 FY26
FY25
$65.2B
Revenue
$46M
FY25
Change
Change
LLY
1,411.70
▼
−0.41%
vs
PTGX
141.91
▼
−2.03%
Regular session
Nov 2 '26